Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neuropsychiatric disorder with a complex genetic background. The G protein-coupled receptor kinase interacting ArfGAP 1 (GIT1) gene was previously associated with ADHD. We aimed at replicating the association of GIT1 with ADHD and investigated its role in cognitive and brain phenotypes. Gene-wide and single variant association analyses for GIT1 were performed for three cohorts: (1) the ADHD meta-analysis data set of the Psychiatric Genomics Consortium (PGC, N Œ 19,210), (2) the Dutch cohort of the International Multicentre persistent ADHD CollaboraTion (IMpACT-NL, N Œ 225), and (3) the Brain Imaging Genetics cohort (BIG, N Œ 1,300). Furthermore, functionality of the rs550818 variant as an expression quantitative trait locus (eQTL) for GIT1 was assessed in human blood samples. By using Drosophila melanogaster as a biological model system, we manipulated Git expression according to the outcome of the expression result and studied the effect of Git knockdown on neuronal morphology and locomotor activity. Association of rs550818 with ADHD was not confirmed, nor did a combination of variants in GIT1 show association with ADHD or any related measures in either of the investigated cohorts. However, the rs550818 risk-genotype did reduce GIT1 expression level. Git knockdown in Drosophila caused abnormal synapse and dendrite morphology, but did not affect locomotor activity. In summary, we could not confirm GIT1 as an ADHD candidate gene, while rs550818 was found to be an eQTL for GIT1. Despite GIT1's regulation of neuronal morphology, alterations in gene
492Neuropsychiatric Genetics expression do not appear to have ADHD-related behavioral consequences. Ă 2015 Wiley Periodicals, Inc.Key words: GIT1; ADHD; brain imaging genetics; eQTL;
Drosophila melanogaster
INTRODUCTIONAttention Deficit/Hyperactivity Disorder (ADHD) is a common and highly heritable neuropsychiatric disorder (heritability 70-80% [Faraone et al., 2005;Burt 2009]), with prevalence rates of 5-6% in childhood [Polanczyk et al., 2007; American Psychiatric Association 2013]. Clinically, ADHD is characterized by two core symptom domains: inattention and hyperactivity/impulsivity [American Psychiatric Association, 2013]. At least 15% and up to 60% of all patients diagnosed in childhood still meet full ADHD criteria when they reach adulthood; prevalence rates of persistent ADHD in adults range between 2.5 and 4.9% [Simon et al., 2009]. The clinical manifestation of adult ADHD may differ from that of childhood ADHD, i.e., by less obvious symptoms of hyperactivity and impulsivity [Haavik et al., 2010;. However, adult individuals with ADHD might be the most severe cases, given the lifelong impairment [Franke et al., 2012 ;Dalsgaard et al., 2015].Despite its high heritability, identifying ADHD risk genes has been difficult [Franke et al., 2009a;Gizer et al., 2009], Due to the disorder's complex genetic background [Franke et al., 2012]. Because of the high prevalence of ADHD in the population, the search for...